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Abstract
Mutations in genes for any of the six subunits of NADPH oxidase cause chronic granulomatous disease (CGD), but almost 2/
3 of CGD cases are caused by mutations in the X-linked CYBB gene, also known as NAD (P) H oxidase 2. Approximately 260
patients with CGD have been reported in Japan, of whom 92 were shown to have mutations of the CYBB gene and 16 to
have chromosomal deletions. However, there has been very little detailed analysis of the range of the deletion or close
understanding of the disease based on this. We therefore analyzed genomic rearrangements in X-linked CGD using array
comparative genomic hybridization analysis, revealing the extent and the types of the deletion genes. The subjects were
five Japanese X-linked CGD patients estimated to have large base deletions of 1 kb or more in the CYBB gene (four male
patients, one female patient) and the mothers of four of those patients. The five Japanese patients were found to range
from a patient exhibiting deletions only of the CYBB gene to a female patient exhibiting an extensive DNA deletion and the
DMD and CGD phenotype manifested. Of the other three patients, two exhibited CYBB, XK, and DYNLT3 gene deletions. The
remaining patient exhibited both a deletion encompassing DNA subsequent to the CYBB region following intron 2 and the
DYNLT3 gene and a complex copy number variation involving the insertion of an inverted duplication of a region from the
centromere side of DYNLT3 into the deleted region.
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Introduction
Chronic granulomatous disease (CGD [OMIM 306400]) is
caused by a reduced nicotinamide adenine dinucleotide phosphate
(NADPH) oxidase complex deficiency and is a primary immuno-
deficiency that impairs the bacteria-killing ability of phagocytes in
the innate immune system and occurs with an incidence of 1 in
200,000 births per year [1]. The NADPH oxidase complex is
localized in the cell membrane and is composed of heterodimeric
membrane-bound flavocytochrome subunits formed from gp91
phox
(phox for phagocyte oxidase [OMIM 300481]) and p22
phox
(OMIM 233690) and cytoplasmic subunits formed from p47
phox
(OMIM 233700), p67
phox (OMIM 233710), p40
phox, and Rac2
(OMIM 602049). Reactive oxygen species (ROS) required to kill
microorganisms, such as superoxide anions (O2
N2) and hydrogen
peroxide, are produced by the transfer of electrons from NADPH
to oxygen molecules. In CGD, however, since the NADPH
oxidase complex is defective or dysfunctional, it is not possible to
kill microorganisms, although the leukocyte phagocytoses the
microorganisms, and this leads to repeated infections by fungi and
catalase-positive bacteria, such as Staphylococcus, Pseudomonas
aeruginosa, Escherichia coli, and Klebsiella pneumoniae, and
frequently causes fatal granulomatous inflammation.
Mutations in genes for any of the six subunits of NADPH
oxidase cause CGD, but almost 2/3 of CGD cases are caused by
mutations in the X-linked CYBB gene, which codes for gp91
phox.
Other CGD patients all show autosomal recessive inheritance
patterns. CYBB is located at Xp21.1 and is a 33.4 kb gene made
up of 13 coding exons and a promoter region mainly expressed in
phagocytes. Its mutations have been reported to include non-sense
mutations, missense mutations, splice site mutations, duplications,
deletions, and insertions [2]. In Japan, more than 260 patients
with CGD have been reported [3]. Genetic analysis of the 92
patients with CYBB gene mutations was performed. Mutations
similar to those in the above reports were found, but in five of the
16 cases exhibiting deletions, the deletion was estimated to be large
at 1 kb or more. Quite recently, details have been revealed from
two patients of five exhibiting contiguous gene syndrome (CGS)
associated with deletions of the XK gene responsible for McLeod
syndrome (OMIM 314850) and the ornithine transcarbamylase
(OTC) gene responsible for OTC deficiency (OTCD [OMIM
311250]) [4].
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and multigene deletions with conventional PCR-SSCP analysis
and DNA sequencing, hindering the precise search for gene
duplications and the detection of heterozygous deletions and
duplications in female carriers. In addition, it is technically difficult
to use Southern blot analysis for high precision, extensive deletion
searches. Because of this, the details of the types of genomic
rearrangements including duplications and deletions (genomic
copy-number losses and gains) and their ranges (sizes and
boundaries) in X-linked CGD caused by mutations in the CYBB
gene are largely unresolved.
Array comparative genomic hybridization (aCGH) is a method
that has been successfully adapted to the detection of copy number
variations (CNVs) in OTCD and Duchenne/Becker muscular
dystrophy (DMD [MIM 310200]), has been confirmed to show
high sensitivity compared with traditional methods currently
available, and has been developing rapidly in recent years [5,6]. In
the present study, we analyzed genomic rearrangements in
Japanese X-linked CGD patients using aCGH analysis, revealing
the extent and the types of the deletion genes.
Results
Search for the CYBB gene and XK gene by PCR
In patients 1, 3, and 4, neither exon 1 nor exon 13 of the CYBB
gene was detected. In patient 2, exon 1 of the CYBB gene was
detected, but exon 13 was not. In patient 5, both exon 1 and exon
13 of the CYBB gene were detected. A search for the XK gene was
performed. Exon 1 of the XK gene was detected in patients 1, 2,
and 5, but not in patient 3 or 4. In the healthy controls, on the
other hand, exons 1 and 13 of the CYBB gene and exon 1 of the
XK gene were clearly detected (Figure 1). These results suggested
that while genes are present upstream of the XK gene in patient 1,
at the very least, all CYBB gene exons are deleted, and that
extensive deletions encompassing the CYBB gene and XK gene are
exhibited in patients 3 and 4. Deletion of CYBB exon 13 and the
centromere side was suspected in patient 2. Patient 5 exhibited a
similar gene amplification pattern to the healthy controls, and no
obvious abnormality was observed.
Deletion search by aCGH
The results of the search for CNVs by aCGH are summarized
in Table 1. Deletions were observed in all five patients. Patient 1
showed the smallest deletion of the five patients at 58.7 kb, starting
upstream of the CYBB gene and including all the exons of the
33.4 kb CYBB gene (Figure 2). Patient 2 was shown to exhibit a
complex CNV involving a deletion of 84.4 kb encompassing the
region downstream of exon 1 of the CYBB gene and the DYNLT3
gene base sequence and a base sequence duplication of 91.9 kb
adjacent to the centromere side of the deletion region (Figure 3).
Patients 3 and 4 showed large deletions of 0.59 Mb and 1.94 Mb,
respectively, encompassing the XK and CYBB genes and the
DYNLT3 gene (OMIM 300302), the function of which is not yet
clear (Figure 4). Patient 5 showed an extensive deletion (5.71 Mb),
exhibiting deletion of exons 1 to 42 of the 79 exons making up the
DMD gene in addition to deletion of the DYNLT3 gene, CYBB
gene, and XK gene (Figure 5). aCGH of the mother of patient 5
also revealed a deletion of the same extent as in patient 5. The size
of the genomic DNA deletions is half of that in the healthy female
controls. Specifically, this shows that patient 5 has a deletion in the
maternally inherited X-chromosome. With the exception of the
mother of patient 4, who could not be tested, the mothers of the
other four patients all had the same CNVs as their children, and
the CNVs in patient 4 were heritable, rather than de novo
(Table 1).
Breakpoint analysis
A common TA base sequence was observed at breakpoints in
patient 1 and the deletion of chrX:g.37364030_37428980del64950
(UCSC hg17 May 2004) was observed (Figure 2).The breakpoint at
Figure 1. PCR Amplification Results for Exons 1 and 13 of the Chronic Granulomatous Disease Gene CYBB and Exon 1 of the McLeod
Syndrome Gene XK Region. The analysis used the Agilent 2100 Bioanalyzer. Patients 1 to 5 were juvenile patients with chronic granulomatous
disease, and genes from normal boys were amplified as a control. CYBB exon 1 was detected only from patients 2 and 5, and CYBB exon 13 only from
patient 5. In addition, XK exon 1 was detected in patients 1, 2 and 5.
doi:10.1371/journal.pone.0027782.g001
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to be chrX:g.37398670 in intron 2 of the CYBB gene (Figure 3). The
base sequence detected at the breakpoint was 59-AGGTAT|GT-
GAGCTGCCAC---- 39 (| denotes the breakpoint). A search using
NCBI Blast Human Sequences showed that this base sequence
corresponded to a sequence inversion observed from chrX:g.
37612397 on the telomere side of the complementary strand. On
the other hand, a search in the neighborhood of chrX:g.37612392,
thought to be the breakpoint on the centromere side, found the
normal 59-GTGGCAGCTCAC|ATACCTAATCTGGACAG-
C----39 chromosomal base sequence. Because of this, it is thought
that a 91.9 kbbase sequenceduplicationaswell asthe deletion ofan
84.4 kb base sequence shown by the results including aCGH
analysis occurred in patient 3, and that since the duplicate
centromere side end had the sequence 59-AGGTAT-39 on the
complementary strand, one of the duplicate strands must have
inverted and recombined with the common 59-AGGTAT-39
sequence at the telomere side of the 59 breakpoint of the 84.4 kb
deletion. However, although the base sequence of the binding
region thought to be present between the duplicate strands was
investigated by the step-by-step PCR method and DNA walking
analysis, it is as yet unclear.
Investigation of skewed lyonization by methylation
specific PCR
The analysis was conducted using peripheral blood mononu-
clear cells (PBMCs) from patient 5 and her mother. An abnormal
(with deletion) X-chromosome from the mother (X1: 186 bp allele)
and a normal X-chromosome from the father (X2: 195 bp allele)
had been inherited. In the patient, a markedly skewed inactivation
pattern was observed in which X-chromosomes from which genes
had been deleted were activated and X-chromosomes with normal
gene alleles were inactivated (Figure 6).
Discussion
The aCGH analysis showed gene deletions of various sizes
ranging from 58.7 kb to 5.71 Mb. In patient 1, only the CYBB
gene was deleted, whereas CGS associated with simultaneous
deletions of adjacent genes occurred in the other patients.
In patients 1 and 2, precise breakpoints were analyzed by direct
sequencing methods after amplification with PCR and DNA
walking. Analysis of four patients including two patients
4
previously reported by us found two cases in which all genes
within the breakpoints were deleted and one case each of complex
Figure 2. The Results of aCGH and Direct Sequence Analysis Spanning the Deletion Breakpoints in Patient 1. A female’s DNA was used
for the control DNA. aCGH analysis showed the deletion region to be 58.7 kb and direct sequencing after amplification by PCR showed that genes
had been deleted from 37364030 to 37428980 (UCSC hg17 May.2004) and both breakpoints were bound.
doi:10.1371/journal.pone.0027782.g002
Table 1. The Results of aCGH Analysis of the Length of the Gene-Deleted Region and Disease Genes.
Patient Sex Deletion gene Genotype (UCSC hg17 May 2004)
aCGH
Deletions
size (kb) mother
1M CYBB chrX:g.(37367763_37367821)_(37426362_37426421) del 58.7 carrier
2M CYBB, DYNLT3 chrX:g.(37402945_37403004)_(37487331_37487390) del 84.4 carrier
chrX:g.(37514480_37514539)_(37606312_37606370) dup 91.9
3M XK, CYBB, DYNLT3 chrX:g.(37128233_37128292)_(37722014_37722073) del 593.8 carrier
4M XK, CYBB, DYNLT3 chrX:g.(35599031_35599090)_(37543467_37543526) del 1944.5 -
5F DMD, XK, CYBB, DYNLT3 chrX:g.(32167387_32167446)_(37878746_37878805) del 5711.4 carrier
CYBB, cytochrome b-245, beta polypeptide; XK, X-linked Kx bood group gene; DMD, Duchenne muscular dystrophy gene; DYNLT3, dynein, light chain, Tctex-type3.
doi:10.1371/journal.pone.0027782.t001
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PLoS ONE | www.plosone.org 3 February 2012 | Volume 7 | Issue 2 | e27782Figure 3. The Results of aCGH and Direct Sequence Analysis Spanning the Deletion Breakpoints in Patient 2. A female’s DNA was used
for the control. According to aCGH, the deletion site was 84.4 kbp and the duplication site 91.9 kb. According to the DNA walking analysis by PCR, a
breakpoint was located at 37398670 of CYBB intron 2. Furthermore, six bases of the gene at 37612392 (UCSC hg17 May.2004) of ATACCT were bound
inverted at the breakpoint, and complex structural abnormalities showing gene deletions on the inner side and duplication of the inverted part were
observed.
doi:10.1371/journal.pone.0027782.g003
Figure 4. The Results of aCGH Analysis Spanning the Deletion Breakpoints in Patients 3 and 4. A female’s DNA was used for the control
DNA for patient 3, and a male’s for patient 4. These male infants suffered deletions of three genes: the chronic granulomatous disease gene (CYBB),
the McLeod syndrome gene (XK), and DYNLT3. The gene deletions in each patient were found to be 0.59 Mb and 1.94 Mb, respectively.
doi:10.1371/journal.pone.0027782.g004
CNVs in X-Linked CGD
PLoS ONE | www.plosone.org 4 February 2012 | Volume 7 | Issue 2 | e27782Figure 5. The Results of aCGH Analysis Spanning the Deletion Breakpoints in Mother and Patient 5. A female’s DNA was used for the
control DNA. This case involved deletions of four genes, the chronic granulomatous disease gene (CYBB), the Duchenne muscular dystrophy gene
(DMD), the McLeod syndrome gene (XK), and DYNLT3. The gene deletion region was about 5.71 Mb and encompassed an area from CYBB to the
greater part of the DMD (b). A similar gene deletion was also observed in the mother (a).
doi:10.1371/journal.pone.0027782.g005
Figure 6. The Results of an Analysis of X-Chromosome Inactivation and Activation Patterns in the Chronic Granulomatous Disease
Sufferer Patient 5 and Her Mother. The female infant had inherited an abnormal (with deletion) X-chromosome X1 from the mother and a
normal X-chromosome X2 from the father. A random inactivation pattern of 69:31 was observed in the mother (carrier). In the female patient,
however, a markedly skewed X-chromosome inactivation pattern of 95:5 (with activation of the X-chromosome with gene deletions transmitted from
the mother and inactivation of the X-chromosome with the normal genes transmitted from the father) was observed.
doi:10.1371/journal.pone.0027782.g006
CNVs in X-Linked CGD
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further inversions in addition to deletions. The ends in four
patients had no gene sequences expected to result in a common
breakpoint.
Chromosomal deletions require a search over the entire range
since variation in extent may produce false negatives by PCR and
duplication of other regions may be involved. Conventionally,
chromosome banding and fluorescence in situ hybridization
(FISH) [7–9] have been used for analysis of chromosomal
deletions, duplications, and translocations, but with chromosome
banding, the detection limit is 1 Mb or more even in analyses with
well-resolved prometaphase chromosomes. On the other hand, a
combination of PCR and automated fluorescent DNA sequencing
allows analysis of single base mutations on the chromosome and
offers the highest resolution. However, the length of the deletion
varies depending on the patient and for larger deletions, it is
difficult to set primers. In addition, when no PCR products are
generated, it is thought that nucleotide insertion into the deletion
site or mutations in the base sequence at the primer binding site
may have occurred. In recent years, aCGH has been developed
and come into use as a method of analyzing CNVs on
chromosomes. In principle, aCGH is a method of adhering a
human gene-specific oligonucleotide probe to a glass slide and
competitively hybridizing it with patient and control DNA, each
labeled with different fluorochromes, and detecting deletions in the
genome and amplification at a resolution of several kb by
measuring the fluorescence. But while this method has high
specificity and high resolution, it has the disadvantage including
difficulty in identifying chromosomal translocations.
Deletions due to genomic mutations are often caused by tandem
repeats and interspersed repeats. Interspersed repeats in particular
include shorts direct repeats, interspersed repeat elements (e.g. Alu
repeats), inverted repeats, low copy number long repeats, and active
transposable elements and are prone to large scale deletions and
duplications [10,11]. In patient 1, the entire CYBB gene within the
breakpoints was deleted. The CYBB gene in patient 2 was found up
to exon 2 and entirely deleted from exon 3. Moreover, it displayed a
complex structure in which the breakpoint chrX:g.37398670 bound
to the base sequence inverted from 37612392 and the region
downstream of 37612392 (UCSC hg17 May. 2004) exhibited a
successive existing base sequence. Alu sequences, which existed the
most, were observed in the neighborhood of the ends, but were not
directly involved in the breakpoints.
Patient 5 was female but was diagnosed with CGD, having a
history of increased susceptibility to infection and confirmed as 46,
X del (X) (p 21.1 p.21.2) on chromosome banding. aCGH showed
that the mother was a carrier with an X-chromosome with the
same deletion as the patient. The existence of skewed lyonization
was investigated by analysis of X-chromosome inactivation on the
basis of DNA methylation [12]. In the analysis of the patient and
her mother, she had inherited an abnormal X-chromosome (X1:
186 bp allele) from her mother and a normal X-chromosome (X2:
195 bp allele) from her father. A markedly skewed inactivation
pattern was observed in the patient, where the X-chromosome
with deleted genes was activated and the X-chromosome having
the normal genetic allele was inactivated (Fig. 6). In consideration
of these results and of the measured percentage of gp91-positive
cells in the patient’s neutrophils (markedly low at about 5%) in
addition to the notably decreased ability to produce ROS when
measured by the NBT assay (as described later in the ‘‘Materials
and Methods’’ section), the normal X-chromosome was thought to
be inactivated in the majority of cells of this patient, which was
believed to be a factor at the onset of the disease (a symptomatic
carrier). Each cell expresses alleles from only one X-chromosome.
Reports on skewed lyonization include Bruton tyrosine kinase
(BTK) deficiency (OMIM 300300) [13], DMD [14] and CGD
[15–17], however, CGS associated with deletions to the same wide
extent as in this patient has not been observed. Francke et al. [18]
reported the case of a male infant in which CGD with extensive X-
chromosome deletions was complicated by DMD, retinitis
pigmentosa, and mental retardation. Here, we analyzed the case
of a female infant who exhibited a similar phenotype with an
extensive genomic deletion and revealed that the X-linked
recessive disorder of women was caused by skewed lyonization.
While chromosomal deletions, inversions, and duplications
occur singly or in combination, reciprocal recombinations due to
translocations have been reported [19–21]. In patient 1, it was
speculated that gene rearrangements due to non-homologous end-
joining (NHEJ) showing the repeated sequence of only two bases
(TA) at the ends of the deleted gene may have occurred
(Figure 7.1a, 1b). Patient 2 had a complex structural abnormality,
and it was hypothesized that this may have been caused by fork
stalling and template switching (FoSTeS)/microhomology-medi-
ated break-induced replication (MMBIR) [22,23]. In patient 2, a
three base repeat sequence of AAT prone to cause changes in copy
number or sequence swaps was observed in the original DNA
strand that acts as a template for the lagging strand during DNA
replication. This AAT is thought to bind to a complementary
DNA sequence of TTA nearby on the same strand of DNA,
forming a loop and inhibiting expansion of the replication fork
(Figure 7.2a). Furthermore, releasing the leading strand with the
free 39 end, AGGTAT, and binding to the complementary strand
ATACCT of another replication fork, a leading strand 59-
AGGTATGTGAGC----39 was synthesized (Figure 7.2b). The
gene synthesized on the leading strand is hypothesized to cause
structural abnormalities leading to duplications and inversions of
the DNA strand subsequent to the deleted DNA strand by a return
to the lagging strand after the end of replication and the binding of
the 59---- GCTCACATACCT-39 telomere side terminus with the
normal gene to the 59-AGGTATGTGAGC----39 centromere side
terminus gene by DNA ligase (Figure 7.2c). As far as we could find,
while a breakage-fusion-bridge cycle has been reported as a
mechanism for large structural abnormalities causing deletions,
inversions, and duplications during chromosome division [23], no
cases of structural abnormalities occurring in the vicinity of the
same gene have been observed.
Materials and Methods
Subjects
The subjects were five Japanese X-linked CGD patients
estimated to have large base deletions of 1 kb or more in the CYBB
gene (fourmale patients,onefemalepatient)andthemothersoffour
of these patients. The four malepatients werediagnosed asCGDon
the basis of the past history with increased susceptibility to infection,
andof deficiencies inROSproductivitybythenitrobluetetrazolium
test (NBT) and the neutrophil chemiluminescence method. Two of
the male patients exhibited reduced expression of erythrocyte Kell
blood group antigen, acanthocytosis, and also high serum CPK
activity. In the female infant patient, in addition to a history of
increased susceptibility to infection at the age of 11 and a marked
reduction in ROS productivity to around 5% of normal,
chromosome banding showed 46, X, del (X)(p21.1p21.2), and
CGD was clinically diagnosed.
DNA isolation
All the patient samples in the present study were used with the
approval of the Saitama Children’s Medical Center Ethics
CNVs in X-Linked CGD
PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e27782Committee and after obtaining written informed consent, and the
procedures were conducted to the principles expressed in the
Declaration of Helsinki, 2008. Patient’s parents provided written
informed consent. DNA was extracted with a DNA Blood Mini
Kit (Qiagen, Valencia, CA) after isolation of heparinized PBMCs.
PCR-band studies
CYBB gene and the adjacent X-linked Kx blood group-related
XK gene were amplified by PCR and the detection of individual
genes was attempted using the Agilent 2100 Bioanalyzer (Agilent
Technologies, Santa Clara, CA) according to the manufacturer’s
instructions. The following primers were used for PCR: CYBB ex1:
forward, 59-AATGTGTTTTACCCAGCACG-39 and reverse, 59-
TGCTTTGGTCTATTTTAGTTCC-39; CYBB ex13: forward,
59-TAGACATCTCATCCCAAAGC-39 and reverse, 59-TTA-
TTTGAGCATTTGGCAGC-39; XK ex1: forward, 59-TTTCCC-
AAGATAGGACCC-39 and reverse, 59-GTTGAACCACAA-
GAAACTGC-39.
aCGH analysis
aCGH measurements used the Agilent Genomic DNA Labeling
Kit (Agilent Technologies). In brief, 1 mg of each of the patient and
control DNA (patients 1, 2, and 3: gender non-matched reference
controls, patients 4 and 5: gender matched reference controls)
were digested with two restriction enzymes (AluI and RsaI; Life
Technologies, Carlsbad, CA). Random-primed DNA labeling was
performed according to the manufacturer’s recommended proto-
col using Cy3-dUTP for patient DNA and Cy5-dUTP for control
DNA. After reacting at 37uC for 2 hrs, labeled patient and control
DNA were purified using DNA Microcon YM-3-filter units
(Millipore, Billerica, MA), mixed, and human Cot-1 DNA (Life
Technologies) and hybridization buffer (Agilent Technologies)
were added. The mixed samples were applied to microarray slides
(Human Genome CGH Microarray 244A, Agilent Technologies)
and the microarray slides were hybridized in Agilent SureHyb
chambers at 65uC for 40 hrs. After a second washing operation
and microarray scanning (Agilent DNA microarray scanner and
Agilent Scan Control Software), images were extracted using the
Feature Extraction Software (version 9.5.3.1; Agilent Technolo-
gies) and imported into the Agilent CGH-Analytics V3.5.14
Software for analysis, and statistically significant CNVs were
determined using the aberration detection module (ADM)-2
algorithm. For details of the statistical algorithm, the Agilent
Technologies user’s manual is available (http://www.agilent.com/
chem/goCGH). Copy-number size was measured as the difference
between the first and last probe position in the region deleted using
the algorithm. The chromosome resolution of DNA variants with
this method averaged 6.4 kb.
Figure 7. Genomic Rearrangement Mechanisms. For the gene deletions in patient 1, gene rearrangements exhibiting deletions due to non-
homologous end-joining (NHEJ) were thought to have occurred, since repeated two base sequences of TA were observed at both ends of the gene
(1a, 1b). In patient 2, it was hypothesized that rearrangement might have occurred through a mechanism involving a combination of fork stalling and
template switching (FoSTeS)/microhomology-mediated break-induced replication (MMBIR). A three base repeat sequence of AAT prone to cause
changes in copy number or sequence swaps was observed in a discontinuous end of the lagging strand during DNA replication. This formed a loop
by binding to TTA on its complementary strand with replication slippage occurring (2a). At the discontinuous end, the lagging strand with the loop
formed had a six base microhomology of AGGTAT and dissociated. The dissociated end subsequently bound to the ATACCT found at the duplication
front of the leading strand. Synthesis and extension of the leading strand then occurred originating from the binding site (2b). The gene synthesized
on the leading strand is hypothesized to cause structural abnormalities leading to duplications of the DNA strand subsequent to the DNA strand
deletion by returning to the lagging strand after the end of duplication and the binding of the end that has finished duplication to the starting end of
the normal gene on the lagging strand by DNA ligase (2c).
doi:10.1371/journal.pone.0027782.g007
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Breakpoints were analyzed in patients 1 and 2. Deletions of
telomeric and centromeric breakpoints revealed by the aCGH
results of patient 1 were determined by the previously reported
step-by-step PCR method [4] using the TAKARA Ex Taq
(Takara Bio, Tokyo, Japan). Finally, after amplification by PCR
with primers set to sandwich the telomeric and centromeric
breakpoints, direct sequence analysis (ABI 310, Life Technologies)
of the PCR product was performed. In patient 2, on the other
hand, as shown in the results, it was not possible to find the
breakpoints by the method described above. To determine the
deletion breakpoints, a DNA walking analysis was conducted
according to the manufacturer’s instructions (DNA Walking Kit;
Seegene, Rockville, MD). For patient 2, gene-specific primary 1stF
59-GGAATCTACTGTGGAAATGC-39, 2ndF 59-TGTTACAT-
CATGCTGAAACTATG-39, 3rdF 59-TCCCGCCAAAATATG-
CAAC-39 and nested primers designed based on the base sequence
near the telomeric breakpoint region were used for PCR
amplification in combination with primary and nested PCR to
Genome Walker Adaptors. To confirm the results, gene-specific
primes were designed to straddle the deletion breakpoints, and
PCR products were amplified from genomic DNA. PCR products
were analyzed by direct sequence analysis. Gene sequences
obtained from the analysis were searched for genetic information
using the NCBI’s BLAST Human Sequences (http://www.ncbi.
nlm.nih.gov/genome/seq/BlastGen/BlastGen.). Androgen Re-
ceptor in the X-chromosome (the HUMARA region) of patient
5 was analyzed by methylation specific PCR and examined for
skewed lyonization [12].
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